New Guide Salesforce ALS-Con-201 Files | ALS-Con-201 Questions Exam

P.S. Free 2026 Salesforce ALS-Con-201 dumps are available on Google Drive shared by Actualtests4sure: https://drive.google.com/open?id=17Mi3zc1JkXb8elXyVp2VGq2FYaM70uDB

With the arrival of a new year, most of you are eager to embark on a brand-new road for success (ALS-Con-201 test prep). Now since you have made up your mind to embrace an utterly different future, you need to take immediate actions. Using ALS-Con-201 practice materials, from my perspective, our free demo is possessed with high quality which is second to none. This is no exaggeration at all. Just as what have been reflected in the statistics, the pass rate for those who have chosen our ALS-Con-201 Exam Guide is as high as 99%, which in turn serves as the proof for the high quality of our practice torrent.

Salesforce ALS-Con-201 Exam Overview:

Certification Vendor:Salesforce
Exam Name:Salesforce Certified Agentforce Life Sciences Consultant
Exam Number:Als-Con-201
Exam Duration:105 minutes
Exam Price:$200 USD
Real Exam Qty:60
Certificate Validity Period:2 years
Passing Score:63%
Exam Format:Multiple Select, Multiple Choice
Related Certifications:Salesforce Certified Sales Cloud Consultant
Salesforce Certified Administrator
Available Languages:English
Sample Questions:Salesforce ALS-Con-201 Sample Questions
Exam Way:Online proctored exam
Pre Condition:Recommended: Salesforce Certified Administrator and Salesforce Certified Sales Cloud Consultant certifications; experience with Salesforce Health Cloud
Official Syllabus URL:https://trailhead.salesforce.com/credentials/agentforce lifes sciences consultant

>> New Guide Salesforce ALS-Con-201 Files <<

ALS-Con-201 Questions Exam - ALS-Con-201 Exam Exercise

Many learners feel that they have choice phobia disorder whiling they are choosing reliable ALS-Con-201 test guide on the internet. If so you can choose our ALS-Con-201 certification materials. We are the leading position in this field and our company is growing faster and faster because of our professional and high pass-rate ALS-Con-201 Exam Torrent materials. Every year more than thousands of candidates choose our reliable ALS-Con-201 test guide materials we help more than 98% of candidates clear exams, we are proud of our ALS-Con-201 exam questions.

Salesforce ALS-Con-201 Exam Syllabus Topics:

TopicDetails
Topic 1
  • Engagement Planning: Focuses on configuring activity plans, managing HCP
  • HCO visit calendars with territory rules, setting up Key Account Management plans, and leveraging Agentforce AI features for optimized planning.
Topic 2
  • Sampling Inventory Management: Addresses end-to-end sample management including allocation limits, GxP regulatory compliance, disbursement workflows, inventory audits, and sample reporting dashboards.
Topic 3
  • Engagement Execution: Covers the full visit lifecycle including remote engagement capabilities, capturing and sharing medical insights, and managing formal Medical Inquiry processes with HCPs and HCOs.
Topic 4
  • Foundations and Administration: Covers core system setup including account and territory configuration, mobile app management, security, consent
  • data privacy, intelligent content, and reporting fundamentals for Agentforce Life Sciences.

Salesforce Certified Agentforce Life Sciences Consultant Sample Questions (Q115-Q120):

NEW QUESTION # 115
Choose 1 option.
Cumulus Pharma wants to roll out Tableau Next to provide its field sales team with real-time performance insights, such as "Visit Plan Attainment," directly within the Agentforce Life Sciences mobile app. The relevant Metrics have been created, the Tableau View component has been added to the Mobile Home Page Lightning record page, and the metadata cache has been refreshed. However, when a field sales rep logs in to the app, the Metrics component displays an error indicating insufficient privileges and the metrics do not load.
Which Tableau Next permission set should the Agentforce Life Sciences Consultant assign to resolve this issue?

Answer: A

Explanation:
The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce's Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.
In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.
Option A, Tableau Next Creator, is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User, is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.
=========


NEW QUESTION # 116
Choose 1 option.
Cumulus Pharma wants to customize the provider summary to include additional information stored in Agentforce Life Sciences for Customer Engagement. An Agentforce Life Sciences Consultant updated the Actionable Relationship Center (ARC) graph used in provider summarization to include additional objects and fields.
How should the consultant ensure that Provider Summary Generation uses the new information to meet business goals?

Answer: A

Explanation:
The correct answer is A because provider summary generation depends on the prompt template and the data supplied to that prompt. In Life Sciences Cloud account summarization, Salesforce documentation references custom prompt templates for account summarization and the account summarization workflow, while the workflow uses the Generate Provider Account Territory Summary flow as part of the summary-generation process. Salesforce also documents that this flow calls actions such as Get Object Relationship Data and Get Life Sciences Configuration Field Names, meaning the flow participates in retrieving relationship-based data, but the generated business summary still needs the prompt template to know what information to use and how to summarize it.
Updating the ARC graph alone makes additional objects and fields available in the relationship structure, but it does not automatically change the prompt's summarization behavior. To ensure the new information is used correctly, the consultant should create a new prompt template version, update the input dataset so the new fields are included, revise the summarization instructions so the AI knows how to use them, and then activate that version. This aligns with Salesforce's guidance that prompt-based generation relies on the configured prompt and its grounding/input data. Option B is incomplete because changing only the flow does not update the prompt's instructions. Option C is also incorrect because batch-job configuration controls bulk execution, not the actual summarization logic.


NEW QUESTION # 117
Choose 1 option.
Cumulus Pharma requires access control for Medical Inquiries. When an inquiry is in the "Draft" stage, the field sales rep who created it should have Edit access. Once it moves to the "Assigned" stage, the rep should only have Read access, while the Medical Science Liaison (MSL) gains Edit access. The solution must dynamically manage Create, Update, and Delete (CRUD) permissions based on the record's current state without using custom Apex sharing.
Which system configuration handles this dynamic security requirement?

Answer: C

Explanation:
Option A is correct because Life Sciences Workflow Management is designed to control what users can do at different stages of a Life Sciences process, including Medical Inquiries. Salesforce Help for configuring Life Sciences workflow paths states that admins define stage operation conditions that must be met to grant users access to operations. Salesforce also provides specific setup guidance for workflow stages used to manage Medical Inquiries, including adding actions to stage operations and configuring stage operation conditions.
This fits the requirement exactly. The access rules change depending on the Medical Inquiry's stage: Draft, Assigned, Responded, Signed, or Submitted. Salesforce's Inquiry object documentation confirms these inquiry statuses are standard values used in the Medical Inquiries process.
Option B is incorrect because criteria-based sharing rules on Case would not dynamically manage stage-specific CRUD behavior for the Life Sciences Inquiry workflow. Also, the question is about Medical Inquiries, not generic Case sharing. Option C is also incorrect because validation rules and dynamic page layouts can restrict or hide fields and actions, but they do not provide the standard stage-based security model required here. Therefore, the consultant should configure Stage Operations and Stage Operation Conditions within Life Sciences Workflow Management.
=========


NEW QUESTION # 118
Choose 1 option.
Cumulus Pharma requires that once a field sales rep finalizes and submits a visit report, it must become immutable and no further edits should be allowed.
Which configuration ensures this behavior?

Answer: A

Explanation:
The correct answer is C because the requirement is to lock a submitted visit report so it can no longer be edited. Salesforce Life Sciences Visit Management supports compliant planning, execution, and reporting for provider visits, and Salesforce Help directs administrators to use the Visit Management Admin Console to configure what fields users can see and how users can interact with and manage visit records.
A submitted visit report often represents a compliance-sensitive record, especially in life sciences, where visit details, sampling activity, consent capture, and inquiry handling may need to remain auditable after submission. Enabling VisitLockHandler enforces the locking behavior, while leaving Unlock submitted visit unchecked prevents the record from being reopened or edited after final submission. This configuration best matches the requirement that the submitted visit report become immutable.
Option A is incorrect because VisitAutoSaveHandler relates to saving visit data, and checking "Allow edits after submission" would contradict the stated requirement. The business specifically wants no further edits after submission. Option B is also incorrect because disabling a permissions handler and setting the status to Closed does not directly enforce immutable submitted-visit behavior. Status alone is not the same as a record lock. Therefore, the consultant should enable VisitLockHandler and ensure submitted visits remain locked by unchecking Unlock submitted visit in the Admin Console.
=========


NEW QUESTION # 119
Choose 1 option.
At Cumulus Pharma, field sales reps report that the Next Best Action component is not visible on the account profile, even though the recommendation data is confirmed to be loaded and synced to mobile.
What is the cause of this issue?

Answer: B

Explanation:
Option B is correct because Life Sciences Cloud for Customer Engagement uses Life Sciences-specific Next Best components for the mobile and account-profile experience. Salesforce's Life Sciences Next Best documentation explains that Next Best Action suggests timely actions such as visits and emails, and the Life Sciences Customer Engagement data model includes Life Sciences-specific recommendation objects such as Territory Account Recommended Action, Territory Account Product Message Score, and Territory Account Score. These are not the same as the generic Einstein Next Best Action component and strategy experience.
The question states that the recommendation data is already loaded and synced to mobile. That removes the most likely data-load or synchronization issue. If the data exists but the component is not visible on the account profile, the issue is most likely the wrong component placement. The page must use the Life Sciences Next Best Action component that is designed to render Life Sciences recommendations in the Life Sciences mobile app.
Option A is not the best answer because inactive strategy logic would generally prevent recommendations from being generated or returned, but the scenario confirms the recommendation data is present. Option C is also less likely because a permission problem would typically prevent access to the recommendation records or data, not specifically indicate that the component itself was configured incorrectly. Therefore, the consultant should replace the generic Einstein Next Best Action component with the Life Sciences Next Best Action component.
=========


NEW QUESTION # 120
......

ALS-Con-201 Questions Exam: https://www.actualtests4sure.com/ALS-Con-201-test-questions.html

What's more, part of that Actualtests4sure ALS-Con-201 dumps now are free: https://drive.google.com/open?id=17Mi3zc1JkXb8elXyVp2VGq2FYaM70uDB